FDA: Propofol Drug Shortage Resolved

The U.S. Food and Drug Administration officially removed propofol from its list of drugs with a supply shortage, according to the American Society of Anesthesiologists.

Advertisement

The drug, commonly used as an ambulatory anesthetic, is available but may take time to move through the supply chain to healthcare facilities, the FDA said in its report.

More Articles on Anesthesia:
MEDNAX Acquires Anesthesia Group of Onondaga in New York
Sagent Pharmaceuticals Recalls Anesthesia Muscle Relaxant
Anesthesia Business Consultants, iMDsoft Develop Cloud-Based Anesthesia EMR

At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.

Register to Attend Webinar

Building a High-Performance Cardiac PET Program: What Health Systems Should Consider

Thursday, July 30
12:00 PM - 1:00 PM CDT

Presenters: Rupa Sanghani, MD, FACC, FASNC, Rush University Medical CenterBrendon Loiselle, CDL Nuclear Technologies

Advertisement

Next Up in Anesthesia

Advertisement

Comments are closed.